
Danaher Corporation DHR
€ 166.82
2.83%
Geschäftsbericht 2025
hinzugefügt 24.02.2026
Danaher Corporation Finanzkreislauf 2011-2026 | DHR
Finanzkreislauf Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.5 | 83.5 | 93.5 | 79.1 | 72.3 | 65.9 | 70.3 | 72.2 | 85 | 79.7 | 72.1 | 64.9 | 66.1 | 76.3 | 85.7 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 93.5 | 64.9 | 76.3 |
Finanzkreislauf Vierteljährlich Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.3 | - | - | - | - | 76 | 67.6 | - | -12.8 | 26.6 | 65.5 | - | -7.61 | -6.79 | 29.5 | 59.8 | -4.84 | -4.96 | 33.5 | 55.5 | -6.66 | -8.3 | 37.4 | 63.2 | 86.2 | 83.3 | 84.5 | 63.4 | 81.5 | 79.5 | 82.3 | 63 | 96.7 | 74.8 | 72.1 | 60.2 | 66.9 | 65.1 | 66.8 | 61 | 67.7 | 66.7 | 74.8 | 59.9 | 78.9 | 76.6 | 80.5 | 59 | 77.1 | 95.6 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 96.7 | -12.8 | 56.2 |
Finanzkreislauf anderer Aktien in der Diagnostik & Forschung
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
111 | $ 117.17 | 1.83 % | $ 35.6 B | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 16.67 | 3.86 % | $ 888 M | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 4.6 | 5.63 % | $ 426 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
NeoGenomics
NEO
|
82.4 | $ 7.96 | 3.51 % | $ 1.02 B | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-2.46 K | $ 1.43 | 4.38 % | $ 1.9 M | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 23.38 | 1.08 % | $ 649 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 177.66 | 1.14 % | $ 8.81 B | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 6.69 | 0.15 % | $ 279 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 497.88 | 0.88 % | $ 14.4 B | ||
|
Neuronetics
STIM
|
17.3 | $ 1.37 | 1.11 % | $ 90.4 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
142 | $ 125.77 | 4.0 % | $ 20 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 511.92 | 3.14 % | $ 193 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 15.3 | 5.99 % | $ 463 M | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.71 | -0.74 % | $ 61.9 M | ||
|
Guardant Health
GH
|
79.6 | $ 81.33 | 3.47 % | $ 10.2 B | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.79 | 3.72 % | $ 90.5 K | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 50.08 | 4.52 % | $ 3 B | ||
|
Biomerica
BMRA
|
172 | $ 2.09 | -1.88 % | $ 4.8 M | ||
|
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 28.56 | 0.88 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 110.47 | 3.43 % | $ 9.11 B | ||
|
Soleno Therapeutics
SLNO
|
-398 | $ 52.66 | 0.05 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 264.01 | 1.18 % | $ 22 B | ||
|
Natera
NTRA
|
81.5 | $ 201.61 | 4.44 % | $ 19.8 B | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 81.19 | 0.74 % | $ 5.48 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
731 | $ 322.55 | 0.75 % | $ 19.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 191.19 | -0.17 % | $ 21.2 B |